Displaying items by tag: research

Class of 2017 option 2Chemistry and philosophy classes, a neuro-oncology lab, hospital volunteer work, and the TKE fraternity were all UAB steppingstones for the first-generation American and Florence High School graduate.
Mitochondrial DNA moving to the nucleus contributes to genomic instability in cancer cells, and a novel Fiber-FISH technique can rapidly map the mitochondrial DNA insertions in nuclear genomes.
These microcarriers may offer an entirely different approach to treating solid human tumors of numerous pathologic subtypes by delivering their encapsulated drug cargo to a tumor and protecting against collateral tissue damage.
Just one month after major research findings showed dangerous PFAS present in more than one-third of fast food packaging tested, UAB and Notre Dame created a new technique to track PFASs in the body.

Unusual case of teen patient diagnosed with colorectal cancer receives innovative first-in-human clinical trial at UAB, reflecting a unique story of cancer and hope.

UAB’s School of Dentistry has ranked first in NIDCR funding since 2012.

New research from UAB sheds light on the connection between Parkinson’s disease and the trillions of bacteria in our guts. 

A 90-ton machine called a cyclotron will accelerate protons to very high speeds to impact human tumors.
The function and structure of protein GARP2 in rod cells of the retina is still not clear, but researchers have shown that GARP2 accelerates retinal degeneration in mice, and have made an important step toward creating a standardized nomenclature between mice and humans for a measurement of retinal degeneration.
Tuberculosis kills 1.8 million people a year, and 10 million more are infected. Development of host-cell directed therapies that could restore cellular function during M. tuberculosis infection, such as a “release and kill” strategy, could shorten drug treatment of TB patients.
Research from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.
Thanks to the popular TV show Blacklist, America is becoming familiar with CRISPR, a revolutionary gene-editing tool. UAB scientists and students explain how it works — and how they are using these “molecular scissors” to cut a path toward genetic cures for sickle cell and brain diseases
David Kimberlin, M.D., vice chair of Pediatrics and co-director of the Division of Pediatric Infectious Diseases, is a physician at Children’s of Alabama. He is the editor of the American Academy of Pediatrics’ Red Book, which establishes which vaccines should be given, when and to whom.
A key Leukemia & Lymphoma Society grant will provide an opportunity for a UAB researcher to develop a new immunotherapy treatment approach for the leukemia most prevalent in Western countries.
UAB secured more than $328.5 million in federal research funding in 2015, ranking the institution No. 18 among public universities and No. 34 overall in the United States during a year in which UAB’s total research and development expenditures exceeded $516 million.
Tagged under

Christopher S. Brown, Ph.D., former vice president of Research for the University of North Carolina System and director and primary investigator of the NASA/North Carolina Space Grant, tapped to grow UAB’s $500 million annual research portfolio.

Page 6 of 57